Form 8-K - Current report:
SEC Accession No. 0001079973-12-000568
Filing Date
2012-07-30
Accepted
2012-07-30 08:10:37
Documents
2
Period of Report
2012-07-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K appy_8k.htm 8-K 29959
2 EXHIBIT 10.1 ex10x1.htm EX-10.1 193821
  Complete submission text file 0001079973-12-000568.txt   224975
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
AspenBio Pharma, Inc. (Filer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33675 | Film No.: 12992064
SIC: 2835 In Vitro & In Vivo Diagnostic Substances